Key Metrics
CiteScore 

9.1
Eigenfactor 

0.005 - 0.01
Impact Factor 

5 - 10
Scite Index 

0.86 5-Year SI

SJR 

Q1Neurology

SNIP 

1.85
Recommended pre-submission checks
Powered by 

Topics Covered on Neurology: Neuroimmunology and NeuroInflammation
Neurology: Neuroimmunology and NeuroInflammation Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | USD 3450 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | American Academy of Neurology |
| Frequency | Bi-monthly |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Neurology: Neuroimmunology and NeuroInflammation ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Neurology: Neuroimmunology and NeuroInflammation
Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38+, CTLA-4+, and PD-1+ T and NK Cells.
- 1 Mar 2026
- Neurology(R) neuroimmunology & neuroinflammation
Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.
- 1 Mar 2026
- Neurology(R) neuroimmunology & neuroinflammation
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.
- 1 Mar 2026
- Neurology(R) neuroimmunology & neuroinflammation
Validation of the MOG-AR Score: A Retrospective Multicenter Study.
- 1 Mar 2026
- Neurology(R) neuroimmunology & neuroinflammation
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.
- 1 Mar 2026
- Neurology(R) neuroimmunology & neuroinflammation
Nasal Foralumab for the Treatment of Progression Independent of Relapses in Patients With Nonactive Secondary Progressive Multiple Sclerosis
- 16 Jan 2026
- Neurology® Neuroimmunology & Neuroinflammation
Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38+, CTLA-4+, and PD-1+ T and NK Cells.
- 1 Mar 2026
- Neurology(R) neuroimmunology & neuroinflammation
Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.
- 1 Mar 2026
- Neurology(R) neuroimmunology & neuroinflammation
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.
- 1 Mar 2026
- Neurology(R) neuroimmunology & neuroinflammation
Validation of the MOG-AR Score: A Retrospective Multicenter Study.
- 1 Mar 2026
- Neurology(R) neuroimmunology & neuroinflammation
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.
- 1 Mar 2026
- Neurology(R) neuroimmunology & neuroinflammation
Nasal Foralumab for the Treatment of Progression Independent of Relapses in Patients With Nonactive Secondary Progressive Multiple Sclerosis
- 16 Jan 2026
- Neurology® Neuroimmunology & Neuroinflammation